Resultados de la búsqueda 61-70 of 2598 for GLP-1 therapy

1. Hematología - Ensayos clínicos - Mayo Clinic

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 ... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy ...

2. Neurología - Ensayos clínicos - Mayo Clinic

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 ... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy ...

3. Neurología - Ensayos clínicos - Mayo Clinic

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

4. Neurología - Ensayos clínicos - Mayo Clinic

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 ... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in combination with doxorubicin (Arm 2) ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types. Rochester, Minn. The purpose of ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types. Rochester, Minn. The purpose of ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 ... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy ...